HP
SRRA

Hikari Power’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Hikari Power’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,503
Closed -$171K – 116
2019
Q4 		$171K Hold
12,503
– – 0.02% 106
2019
Q3 		$195K Buy
12,503
+6,200
+98% +$119K 0.02% 105
2019
Q2 		$141K Buy
6,303
+53
+0.8% +$2.57K 0.02% 111
2019
Q1 		$428K Hold
6,250
– – 0.04% 77
2018
Q4 		$330K Buy
+6,250
New +$399K 0.04% 79

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hikari Power's SRRA Position: Q1 2020 in Review

Hikari Power sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 12,503 shares — an estimated $171K sold.

Hikari Power first reported a position in SRRA in Q4 2018 and held it in 5 quarters. The position peaked at $428K in Q1 2019. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

  • Hikari Power reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Hikari Power sold 12,503 Sierra Oncology, Inc. Common Stock shares in Q1 2020, an estimated $171K.
  • Hikari Power first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
  • Hikari Power's Sierra Oncology, Inc. Common Stock position peaked at $428K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Hikari Power's 13F filing for Q1 2020, filed 23 Apr 2020.